Sort   by:  
 Page size 
UnknownBrentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1-2 trial.
Not available
S-EPMC6487196 | biostudies-literature
UnknownNivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults.
Not available
S-EPMC10646780 | biostudies-literature
UnknownTransplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults: A Nonrandomized Clinical Trial.
Not available
S-EPMC11926625 | biostudies-literature
UnknownA phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study.
Not available
S-EPMC4478135 | biostudies-literature
ProteomicsBioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative - Streptococcus pyogenes
The Antibiotic Resistant Sepsis Pathogens Framework Initiative aims to develop a framework dataset of 5 sepsis pathogens (Escherichia coli, Klebsiella pneumoniae complex, Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes, 5 strains each) using an integrated application of ge...
ORGANISM(S): Streptoccous pyogenes 
2021-07-05 | PXD020863 | Pride
Proteomics Rpmi Streptococcus pyogenes Orbitrap Lfq Sera Antibiotic resistance Sepsis Dda 
Proteomicsi. Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative – Escherichia coli
The Antibiotic Resistant Sepsis Pathogens Framework Initiative aims to develop a framework dataset of 5 sepsis pathogens (Escherichia coli, Klebsiella pneumoniae complex, Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes, 5 strains each) using an integrated application of ge...
ORGANISM(S): Escherichia coli 
2021-07-05 | PXD020545 | Pride
Proteomics Escherichia coli Rpmi Orbitrap Lfq Sera Antibiotic resistance Sepsis Dda 
ProteomicsBioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative - Klebsiella pneumoniae complex
The Antibiotic Resistant Sepsis Pathogens Framework Initiative aims to develop a framework dataset of 5 sepsis pathogens (Escherichia coli, Klebsiella pneumoniae complex, Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes, 5 strains each) using an integrated application of ge...
ORGANISM(S): Klebsiella variicola Klebsiella pneumoniae 
2021-07-05 | PXD020839 | Pride
Proteomics Rpmi Klebsiella Orbitrap Lfq Sera Antibiotic resistance Sepsis Dda 
ProteomicsBioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative - Staphylococcus aureus
The Antibiotic Resistant Sepsis Pathogens Framework Initiative aims to develop a framework dataset of 5 sepsis pathogens (Escherichia coli, Klebsiella pneumoniae complex, Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes, 5 strains each) using an integrated application of ge...
ORGANISM(S): Staphylococcus aureus 
2021-07-05 | PXD020791 | Pride
Proteomics Rpmi Staphylococcus aureus Orbitrap Lfq Sera Antibiotic resistance Sepsis Dda 
GenomicsNational Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments

The Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative seeks to accelerate research in novel marker and drug development, along with understanding the molecular basis of pediatric malignancy, through identification of genomic changes associated with the follo...

phs000218.v5.p1 | EGA
UnknownBiallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy.
Not available
S-EPMC10506156 | biostudies-literature
Sort   by:  
 Page size